---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-077791"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:28:02.516273+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# iBio enters ATM equity facility for up to $7.35M in common stock sales

## Summary
- Entry into ATM Agreement with Chardan Capital Markets and Craig-Hallum Capital Group for at-the-market offerings.
- Aggregate market value of shares eligible for sale under the ATM prospectus supplement is $7,350,000.
- Sales agents receive fixed commission rate of up to 3.0% of gross proceeds.
- Shelf registration statement on Form S-3 filed on July 3, 2024, must be effective before sales can occur.
- Company has no obligation to sell shares and may suspend offerings at any time.

## SEC filing metadata
- accession: 0001104659-24-077791
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000110465924077791/0001104659-24-077791-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000110465924077791/tm2418848d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-077791
- JSON: https://secwatch.observer/filing/0001104659-24-077791.json
- Plain text: https://secwatch.observer/filing/0001104659-24-077791.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.